Study of The Association of Mutations in The NPHS2 Gene and Nephrotic Syndrome in Children and Adults in Middle East
NCT03326037 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2019-01-10
Summary
Nephrotic syndrome (NS) represents one of the most common diagnoses in pediatric and adult nephrology, with a prevalence of 16 per 100,000 children and 3 per 100,000 adults in Western countries.
In most cases, the pathogenesis of NS remains elusive, and the clinical phenotype of patients does not allow discrimination among different causes. Thus, children with NS are usually treated with corticosteroids before a biopsy is taken, and approximately 80% of them respond to such a treatment. According to this observation, pediatric NS has been separated into two broad categories; Steroid-Sensitive Nephrotic Syndrome (SSNS) and Steroid-Resistant Nephrotic Syndrome (SRNS). In both these categories the biopsy result is usually Minimal Change Disease (MCD) while a few may show Focal and Segmental Glomerulosclerosis (FSGS). Although children affected by SSNS have good long-term prognosis, most patients with SRNS progress to End Stage Renal Disease (ESRD) within 2-10 years of diagnosis .
In adults a biopsy diagnosis of FSGS is more common than in children and more patients will not respond to corticosteroids alone and will need additional immunosuppressant medication. About 40% will progress to ESRD within 10 years .
Currently, at least 19 genes have been clearly identified with association to SRNS harboring \~300 independent mutations, conferring a considerable genetic heterogeneity to the disorder.
Genetic testing is emerging as a useful diagnostic tool in SRNS as it has implications for clinical course, treatment response, risk for posttransplant proteinuria and prenatal diagnosis. An approach for genetic testing based on the current evidence seems cost-effective and may help in the best possible management of SRNS .
The NPHS2 gene, is located on chromosome 1 and is also known as the Podocin gene. It encodes the podocin protein. Podocin is a 383-amino acid lipid-raft-associated protein localized at the slit diaphragm, where it is required for the structural organization and regulation of the glomerular filtration barrier. Its interaction with other slit diaphragm proteins eg. nephrin, NEPH1, CD2AP and TRPC6 is important in mechanosensation signaling, podocyte survival, cell polarity, and cytoskeletal organization .
.
It has been reported that variants in the NPHS2 gene are associated with NS .
The commonly studied rs61747728 NPHS2 gene polymorphism also known as p.R229Q has been reported to be associated with NS and SRNS .
However others have failed to report an association , which might be due to population differences.
The rs61747728 is a non-synonymous variant found on exon 5 which is suggested to be involved in in altering the functional properties of podocin in vitro and possibly in vivo .
The investigators will therefore investigate the frequency of the p.R229Q variant in Middle East patients with NS.
Genetic analysis will have important implications in several aspects:-
1. Understanding the biology of the disease in this part of the world.
2. Counselling patients about their clinical course and what medication they will respond to.
3. Counselling patients about the possibility of a kidney transplant sooner in their disease course
Conditions
- Nephrotic Syndrome
Interventions
- GENETIC
-
Genotyping of the NPHS2 variant rs61747728
Genotyping of the NPHS2 variant rs61747728 will be performed by Real-time TaqMan Allelic Discrimination Assay (Life technologies, CA, USA) according to standard manufacturer protocols. Allelic discrimination analysis will be performed and analyzed using ABI 7500 Fast Real-time PCR system SDS software (Life technologies, CA, USA)
Sponsors & Collaborators
-
Kuwait University
collaborator OTHER -
Assiut University
collaborator OTHER -
AHMED ABDULQADER HAMMOUDA ABOU SHALL
lead OTHER
Eligibility
- Min Age
- 2 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-10-31
- Primary Completion
- 2019-10-31
- Completion
- 2020-06-30
Countries
- Kuwait
Study Locations
More Related Trials
-
Study of Adrenocorticotropic Hormone on Children With Frequent Relapse or Steroid-dependent Nephrotic Syndrome: a Prospective, Multicenter, Randomized,Open-label Clinical Trial.
NCT06079788 ·Status: RECRUITING ·Phase: PHASE3
-
Research of Therapeutic Targets in the Frame of Nephronophthisis and Renal Associated Ciliopathies
NCT06648044 ·Status: RECRUITING ·Phase: NA
-
Electrocardiograph Changes and Holter Abnormalities in Children With Predialytic Chronic Kidney Disease
NCT05726071 ·Status: UNKNOWN
-
The Selection of Initial Treatment Regimens for Adolescent Nephrotic Syndrome.
NCT07071597 ·Status: ACTIVE_NOT_RECRUITING
-
Right Ventricular Failure in Congenital Heart Defects
NCT00266201 ·Status: COMPLETED
-
End-organ Pathology in Childhood Essential Hypertension
NCT00005180 ·Status: COMPLETED
-
Autosomal Dominant Polycystic Kidney Disease (ADPKD) Study
NCT04338048 ·Status: RECRUITING
-
Biomarkers and Outcome Predictors of Pediatric Nephrotic Syndrome: A Genetic, Transcriptomic, and Secretome Multiomics Study
NCT06792448 ·Status: NOT_YET_RECRUITING
-
Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.
NCT05505500 ·Status: RECRUITING
-
Cardiac Performance Evaluation in Children With Steroid Dependent vs Steroid Resistant Nephrotic Syndrome
NCT06622915 ·Status: RECRUITING ·Phase: NA
-
Effects of Nesiritide in Pediatric Patients With Heart Failure
NCT00166010 ·Status: WITHDRAWN ·Phase: NA
-
Renal Doppler in Pediatric Patients With Idiopathic Nephrotic Syndrome
NCT05912673 ·Status: COMPLETED
-
INSIGHT (Insight Into Nephrotic Syndrome)
NCT01605266 ·Status: RECRUITING
-
Dyskinesia, Heterotaxy and Congenital Heart Disease
NCT00608556 ·Status: COMPLETED
-
Molecular Genetics of Heterotaxy and Related Congenital Heart Defects
NCT02432079 ·Status: RECRUITING
-
A Phase IV, Two-part, Open-label Study Assessing the Pharmacokinetics, Safety and Pharmacodynamics of Spironolactone Oral Suspension in Pediatric Patients
NCT06021860 ·Status: UNKNOWN ·Phase: PHASE4
-
Availability Study of ACTH to Treat Children SRNS/SDNS
NCT02972346 ·Status: UNKNOWN ·Phase: NA
-
Implementation of a Diagnostic Workflow for Personalized Diagnosis of Nephrotic Syndrome
NCT06325098 ·Status: RECRUITING ·Phase: NA
-
Biomarkers of Pediatric Heart Failure
NCT05969925 ·Status: UNKNOWN
-
Recognition of Abnormal Pediatric Blood Pressures in Primary Care
NCT00130663 ·Status: COMPLETED ·Phase: NA
-
Adrenocorticotropic Hormone (ACTH) for Frequently Relapsing and Steroid Dependent Nephrotic Syndrome
NCT02132195 ·Status: COMPLETED ·Phase: PHASE3
-
Association of Insulin Resistance and FGF21 on Cardiac Function in Pediatric Dilated Cardiomyopathy
NCT04222101 ·Status: TERMINATED ·Phase: NA
-
Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE)
NCT04752293 ·Status: RECRUITING
-
Fibrosis and the Fontan
NCT04901975 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Study of Tacrolimus vs Mycophenolate Mofetil in Pediatric Patients With Nephrotic Syndrome
NCT04048161 ·Status: COMPLETED ·Phase: PHASE4